Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct ...
Instead of dinosaurs, Colossal has set its sights on more recently lost species including the dodo, the thylacine -- also known as the Tasmanian tiger-- and the woolly mammoth. The last confirmed ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Global warming is producing a rapid loss of plant species—according to estimates, roughly 600 plant species have died out ...
The finalists are down to three, The Outlaws, The Utah Hockey Club, and the Mammoth but the big question remains: what will ...
The ancient skull will soon be the centerpiece of a planned ice age exhibit that will feature fossils found across Texas, including those from horses, camels, sloths, and the short-faced bear ...
All of Kostenki's mammoth bones belong to one of the most well-known mammoth species, the woolly mammoth (Mammuthus primigenius). Due to their rich fossil record and the preservation of several ...
Launched in 2021, Dallas-based Colossal Biosciences Inc. aims to reintroduce extinct species, some of which date back to the ...
The scientists used their data to chart where and when plant species emerged or disappeared across Siberia and Alaska.
Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...
Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results